Bacillus Calmette-Guérin (BCG) and Beyond: Is Systemic Immunotherapy for BCG-Naïve Non-Muscle-Invasive Bladder Cancer Progress or Overreach? - PubMed
4 hours ago
- #BCG
- #Immunotherapy
- #Bladder Cancer
- The article discusses the use of Bacillus Calmette-Guérin (BCG) in treating non-muscle-invasive bladder cancer (NMIBC).
- It questions whether systemic immunotherapy for BCG-naïve NMIBC patients represents progress or overreach.
- The discussion includes considerations of the efficacy and appropriateness of extending immunotherapy to BCG-naïve cases.